Surgical treatment Sample Clauses

Surgical treatment. I. All cases, which require conservative management with a minimum of one-week hospitalization with evidence of (Imageology based) seriousness of injury to warrant admission, only need to be covered to avoid misuse of the scheme for minor/trivial cases. II. In case of Neurosurgical trauma, admission is based on both Imageology evidence and Glasgow Coma Scale (A scale of less than 13 is desirable). III. All surgeries related to poly-trauma are covered irrespective of hospitalization period. IV. Initial evaluation of all trauma patients has to be free of cost.
Sample 1Sample 2Sample 3See All (4)
Surgical treatment. All cases, which require conservative management with a minimum of one-week hospitalization with evidence of (Imageology based) seriousness of injury to warrant admission, only need to be covered to avoid misuse of the scheme for minor/trivial cases.
Sample 1Sample 2
Surgical treatment. I. All cases, which require conservative management with a minimum of one-week hospitalization with evidence of (Imageology based) seriousness of injury to warrant admission, only need to be covered to avoid misuse of the scheme for minor/trivial cases. II. In case of Neurosurgical trauma, admission is based on both Imageology evidence and Glasgow Coma Scale (A scale of less than 13 is desirable). III. All surgeries related to poly-trauma are covered irrespective of hospitalization period. IV. Initial evaluation of all trauma patients has to be free of cost. V. The conservative line of treatment in Orthopedics for specified procedures are covered in Aarogyasri II.
Sample 1
Surgical treatment. The mainstay of treatment for endometrial cancer is surgical with total abdominal hysterectomy and bilateral oophorectomy. Current FIGO recommendations for the staging of endometrial cancer include pelvic and para - aortic lymph node biopsy in attempt to define the prognosis and the need for adjuvant therapy (Shepherd 1989). However performing a lymphadenectomy increases the operative time, the risk of intraoperative haemorrhage and the risk of lymphoedema (Xxxx et al. 2003; Kitchener et al. 2009). Patients who had their lymph nodes removed have increased radiotherapy related complications (Xxxxxxxxxx et al. 2000). In early cancers (stage I) the risk of lymph node involvement is variable from 0% in superficial grade 1 tumours to 25% in deep grade 3 tumours. Given the variation in the risk of nodal involvement, performing lymphadenectomy as a routine in all cases remains controversial. On this basis, some have suggested that the decision to perform lymphadenectomy in stage I tumours should be tailored to each individual’s risk of nodal involvement (Xxxxxxxx et al. 1987) as this would avoid lymphadenectomy in patients unlikely to have lymph node involvement thereby sparing these patients operative and postoperative complications. Given that the majority of endometrial cancers are early stage some form of patient selection for lymphadenectomy appears therefore desirable (Hacker et al. 2006). In a retrospective study of over 12,000 patients Xxxx et al. demonstrated a limited therapeutic effect of lymphadenectomy across all stages of endometrial cancer (Xxxx et al. 2006). However these authors could not control for standard of care, co-morbidity and stage migration. They also do not report the rate of postoperative complications in these patients. The therapeutic role of lymphadenectomy is therefore not currently widely accepted.
Sample 1
Surgical treatment. In the current multidisciplinary treatment approach, surgery has been the mainstay of colorectal cancer treatment throughout the years. Formal oncological bowel resection with a primary anastomosis is considered the main therapeutic approach for CRCs as well as for large benign lesions that cannot be removed endoscopically. With increasing attention for organ preservation, surgical and endoscopic alternatives have become more widely available. However, because a formal oncological resection is the only way to excise the draining lymph nodes, local excision is only a valuable treatment alternative in the absence of lymph node metastases (LNM).32 As the risk of LNM varies from about 10% in submucosal invasive CRCs (pT1) to 50% in locally advanced tumours (pT4),33 a formal bowel resection remains the preferred choice of treatment in most cases. However, the benefits of surgery should always be weighed carefully against its risks. One of the most feared complications in colorectal surgery is an anastomotic leak. In the Netherlands in 2017, anastomotic leakage rates were 4.5% and 7.6% following elective surgery for colon and rectal cancer respectively. Overall 30-day mortality rates were 2.1% for colon cancer and 1.1% for rectal cancer.34 However, multiple studies have shown that the 30-day mortality rate highly underestimates the risk of dying in the first year after surgery, indicating that there is a prolonged impact of surgery. Excess one-year mortality rates vary from 15 to 30%.35 Also, a cross-sectional study of low anterior resection for rectal cancer in the Netherlands in 2011 showed that one third of anastomotic leakages was diagnosed beyond 30 days.36 Furthermore, one should also consider the effect of surgery on functional outcomes. For example, sexual function, voiding, bladder function, and faecal continence are all at risk after rectal cancer treatment.37,38 In conclusion, CRC surgery can be considered high-risk surgery.
Sample 1
Surgical treatment. Potentially curative epilepsy surgery involves resection of epileptogenic tissue. A surgical workup is conducted with criteria needing to be met demonstrating intractability. The ILAE has suggested that there must be “a failure of adequate trials of two tolerated, appropriately chosen and used AED schedules whether as monotherapy or in combination to achieve sustained seizure freedom” (Xxxx et al., 2010). Localisation of the epileptogenic zone is of primary importance, generally obtained from prolonged EEG recordings, which might localise the site of seizure onset. Structural imaging can also be of great use in this regard. In addition surgical planning can involve the use of PET and intracranial EEG. Some predictive factors of outcome include an early age of onset and the presence of an epileptogenic MRI lesion, (Xxxxxx et al., 2002), although absence of these features does not preclude epilepsy surgery or its potential success. Patients who had extratemporal resections were more likely to have seizure recurrence, furthermore patients with focal cortical dysplasia are also more likely to have continuing seizures, (xx Xxxx et al., 2011).
Sample 1

Related to Surgical treatment

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • National Treatment In the sectors inscribed in its Schedule, and subject to any conditions and qualifications set out therein, each Party shall accord to services and service suppliers of the other Party treatment no less favourable than that it accords, in like circumstances, to its own services and service suppliers.

  • Equal Treatment No consideration shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered and paid to all the Subscribers and their permitted successors and assigns.

  • Confidential Treatment The parties hereto understand that any information or recommendation supplied by the Sub-Adviser in connection with the performance of its obligations hereunder is to be regarded as confidential and for use only by the Investment Manager, the Company or such persons the Investment Manager may designate in connection with the Fund. The parties also understand that any information supplied to the Sub-Adviser in connection with the performance of its obligations hereunder, particularly, but not limited to, any list of securities which may not be bought or sold for the Fund, is to be regarded as confidential and for use only by the Sub-Adviser in connection with its obligation to provide investment advice and other services to the Fund.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State. (2) In addition, each Contracting Party shall accord to investors of the other Contracting Party, including in respect of returns on their investments, treatment which shall not be less favourable than that accorded to investors of any third State. (3) The provisions of paragraphs (1) and (2) above shall not be construed so as to oblige one Contracting Party to extend to the investors of the other the benefit of any treatment, preference or privilege resulting from: (a) Any existing or future free trade area, customs unions, monetary union or similar international agreement or other forms of regional cooperation to which one of the Contracting Parties is or may become a party, or (b) Any matter pertaining wholly or mainly to taxation.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

  • Sale Treatment The Company has determined that the disposition of the Mortgage Loans pursuant to this Agreement will be afforded sale treatment for accounting and tax purposes;

  • CONFIDENTIAL TREATMENT REQUESTED Confidential portions of this document have been redacted and have been separately filed with the Commission.

  • Equal Treatment of Purchasers No consideration (including any modification of any Transaction Document) shall be offered or paid to any Person to amend or consent to a waiver or modification of any provision of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect to the purchase, disposition or voting of Securities or otherwise.